These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5776422)

  • 21. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 25. Nurses like centralized I.V. additive service.
    Pang FJ
    Hosp Manage; 1970 Aug; 110(2):50-3. PubMed ID: 5514211
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term benefits of a centralized I.V. additive service.
    Skolaut MW
    Am J Hosp Pharm; 1968 Sep; 25(9):536-7. PubMed ID: 5671564
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous additive service improves I.V. preparation.
    Gallelli JF; Peterson WH
    Hospitals; 1968 May; 42(9):78-83. PubMed ID: 5694644
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quality control in the hospital pharmacy].
    Kok JF
    Pharm Weekbl; 1968 Apr; 103(17):486-505. PubMed ID: 5665060
    [No Abstract]   [Full Text] [Related]  

  • 29. Work analysis of an admixture service.
    Sebastian G; Thielke TS
    Am J Hosp Pharm; 1983 Dec; 40(12):2149-53. PubMed ID: 6419588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collecting i.v. workload data.
    Gary-Fritz K; Placko JS
    Am J Hosp Pharm; 1986 Aug; 43(8):1914. PubMed ID: 3752128
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of an I.V. additive program.
    Kahn S
    Bull Parenter Drug Assoc; 1971; 25(5):247-51. PubMed ID: 5094097
    [No Abstract]   [Full Text] [Related]  

  • 33. Centralized intravenous admixture program for nine British hospitals.
    Tallett ER
    Am J Hosp Pharm; 1978 Feb; 35(2):163-5. PubMed ID: 626198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Documenting i.v. admixture product waste.
    Waller DJ
    Am J Hosp Pharm; 1986 Aug; 43(8):1914-5. PubMed ID: 3752129
    [No Abstract]   [Full Text] [Related]  

  • 35. Procedures for handling intravenous additives. The nursing team approach.
    Paoloni CU
    Hosp Manage; 1969 Sep; 108(3):12-22. PubMed ID: 5809799
    [No Abstract]   [Full Text] [Related]  

  • 36. Parenteral distribution in a 262-bed hospital.
    Deliganis SG; Doane R; Pucket WW
    Hospitals; 1974 Nov; 48(22):71-2, 74. PubMed ID: 4435782
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of an IV admixture program in a 167-bed hospital.
    Wyatt BK
    Hosp Pharm; 1975 Jun; 10(6):225-9. PubMed ID: 10237880
    [No Abstract]   [Full Text] [Related]  

  • 38. Why you can also offer an I.V. additive service.
    Bruner WR
    Pharm Times; 1978 Oct; 44(10):66-70. PubMed ID: 10238894
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities and significance of the production of infusion solutions in hospital pharmacies].
    Frank P
    Infusionstherapie (1973); 1974 Apr; 1(4):319-23. PubMed ID: 4219374
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting pharmaceutical incompatibilities of parenteral medications.
    Carlin HS; Perkins AJ
    Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.